EcoDrugPlus

Ensembl ID : ENSOMYG00000040011
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSOMYG00000040077
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSOMYG00000040199
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOMYG00000040210
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000069955
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSOMYG00000069936
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSOMYG00000069371
Gene Symbol: -
Cross references: -
340 Possible Orthologues:

Ensembl ID : ENSOMYG00000040397
Gene Symbol: -
Cross references: -
261 Possible Orthologues:

Ensembl ID : ENSOMYG00000040460
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSOMYG00000040530
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Ensembl ID : ENSOMYG00000040618
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSOMYG00000067927
Gene Symbol: -
Cross references: -
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).